SEC Form 4 · accession 0001554795-17-000328
IRIS BIOTECHNOLOGIES INC · IRSB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Simon Chin
Officer — Chief Executive Officer · Director · 10% Owner
Period of report
Aug 9, 2017
Accepted (ET)
Aug 9, 2017 · 5:08 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001396238
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 9, 2017 | J | 416,670 | $0.10 | A | 13,955,820 | D |
Table II — derivative securities
No Table II lines on this filing.
Remarks
$41,667 in salary paid in stock.